UCB - Loan Capital

Stock Price
234.70
Daily Change
-2.30 -0.97%
Monthly
-9.38%
Yearly
46.92%
Q2 Forecast
231.88

UCB reported EUR2.18B in Loan Capital for its fiscal semester ending in December of 2025.





Loan Capital Change Date
Alcon AG USD 4.16B 434M Mar/2026
Almirall EUR 324.81M 61.32M Dec/2025
argenx SE USD 35.57M 3.05M Jun/2025
AstraZeneca USD 25.96B 177M Mar/2026
Bayer EUR 30.68B 1.15B Mar/2026
Genmab DKK 5.14B 5.01B Dec/2025
GlaxoSmithKline GBP 14.01B 696M Mar/2026
GRIFOLS EUR 9.08B 612M Mar/2026
Hikma Pharmaceutical USD 1.49B 692M Dec/2025
Lakefront Biotherapeutics EUR 4.85M 335K Mar/2026
Lonza CHF 3.88B 323M Dec/2025
Merck EUR 10.73B 277M Dec/2025
Novartis USD 37.45B 7.86B Mar/2026
Orion EUR 110.6M 4.7M Mar/2026
Recordati EUR 2.13B 45.92M Dec/2025
Roche Holding CHF 27.43B 966M Dec/2025
Sanofi EUR 13.84B 1.88B Mar/2026
UCB EUR 2.18B 634M Dec/2025
Unibail Rodamco EUR 21.57B 88M Dec/2025